Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with ...

Frankie, a playful baby dachshund just a few months old, is fighting through unimaginable odds after being hit by a car and ...

Novel therapies for certain autoimmune diseases have been developed to end B cell-driven immune attacks on normal tissues.

Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, and Protalix BioTherapeutics, Inc.

South Africa’s provincial health departments have spent more than R11.7 billion on blood and blood products over the past five years, purchasing from two non-profit organisations rather than operating ...

In my 30s, I suddenly found myself miraculously blessed with a rapidly enlarging social circle ...

Omeros Corporation maintained with Strong Buy rating after securing a $2.1 billion partnership with Novo Nordisk for ...

Onctura, a clinical-stage precision oncology company focused on neglected and hard-to-treat cancers, today announces the Phase Ib study investigating oral autotaxin (ATX) inhibitor, cambritaxestat ...

Postpartum depression affects some one in eight women in the United States. It typically occurs in the first weeks after ...